Budget Impact Analysis of Venetoclax for Management of Acute Myeloid Leukemia from the Perspective of the Social Security and the Private Sector in Argentina

A. Palacios,N. Espinola,J. M. Gonzalez,M. M. Rivas,C. Rojas-Roque,D. Kanevsky,P. Morisset,F. Augustovski,D. A. Pichon-Riviere and A. Bardach. BUDGET IMPACT ANALYSIS OF VENETOCLAX FOR MANAGEMENT OF ACUTE MYELOID LEUKEMIA FROM THE PERSPECTIVE OF THE SOCIAL SECURITY AND THE PRIVATE SECTOR IN ARGENTINA. Value in Health. 2022;25(1):https://doi.org/10.1016/j.jval.2021.11.316.